Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors

被引：460

作者：

Liao, Jeffrey Jie-Lou

机构：

[1] TransTech Pharma, High Point, NC 27265 USA

[2] Duke Univ, Dept Chem, Durham, NC 27708 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 03期

关键词：

GROWTH-FACTOR RECEPTOR; CYCLIN-DEPENDENT KINASE; STRUCTURE-GUIDED DESIGN; ABL TYROSINE KINASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; AURORA KINASE; MAP KINASE;

D O I：

10.1021/jm0608107

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：409 / 424

页数：16

共 133 条

[61] Docking and scoring in virtual screening for drug discovery: Methods and applications [J].

Kitchen, DB ;

Decornez, H ;

Furr, JR ;

Bajorath, J .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) :935-949

[62] Features of selective kinase inhibitors [J].

Knight, ZA ;

Shokat, KM .

CHEMISTRY & BIOLOGY, 2005, 12 (06) :621-637

[63] CRYSTAL-STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE-MONOPHOSPHATE DEPENDENT PROTEIN-KINASE [J].

KNIGHTON, DR ;

ZHENG, JH ;

TENEYCK, LF ;

ASHFORD, VA ;

XUONG, NH ;

TAYLOR, SS ;

SOWADSKI, JM .

SCIENCE, 1991, 253 (5018) :407-414

[64] Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design [J].

Kontopidis, G ;

McInnes, C ;

Pandalaneni, SR ;

McNae, L ;

Gibson, D ;

Mezna, M ;

Thomas, M ;

Wood, G ;

Wang, SD ;

Walkinshaw, MD ;

Fischer, PM .

CHEMISTRY & BIOLOGY, 2006, 13 (02) :201-211

[65] Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor [J].

Krystof, V ;

McNae, IW ;

Walkinshaw, MD ;

Fischer, PM ;

Müller, P ;

Vojtesek, B ;

Orság, M ;

Havlícek, L ;

Strnad, M .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (15) :1763-1771

[66] A GEOMETRIC APPROACH TO MACROMOLECULE-LIGAND INTERACTIONS [J].

KUNTZ, ID ;

BLANEY, JM ;

OATLEY, SJ ;

LANGRIDGE, R ;

FERRIN, TE .

JOURNAL OF MOLECULAR BIOLOGY, 1982, 161 (02) :269-288

[67]

Laird AD, 2000, CANCER RES, V60, P4152

[68]

LIAO JJL, IN PRESS CURR TOP ME

[69] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997) [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :3-26

[70] Drug-like properties and the causes of poor solubility and poor permeability [J].

Lipinski, CA .

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :235-249

← 2 3 4 5 6 7 8 9 10 11 →